Dennis Hoffmann

918 total citations
27 papers, 624 citations indexed

About

Dennis Hoffmann is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Dennis Hoffmann has authored 27 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 15 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Dennis Hoffmann's work include Virus-based gene therapy research (20 papers), CAR-T cell therapy research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Dennis Hoffmann is often cited by papers focused on Virus-based gene therapy research (20 papers), CAR-T cell therapy research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Dennis Hoffmann collaborates with scholars based in Germany, India and United Kingdom. Dennis Hoffmann's co-authors include Oliver Wildner, Klaus Überla, Wibke Bayer, Christian Jogler, Thomas Grünwald, Dirk Theegarten, Hilmar Wisplinghoff, Jörg Czech, Oliver A. Cornely and Ramachandra Naik and has published in prestigious journals such as Journal of Virology, Journal of Investigative Dermatology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Dennis Hoffmann

27 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis Hoffmann Germany 17 384 322 250 138 128 27 624
Xiao‐Mei Rao United States 12 281 0.7× 294 0.9× 149 0.6× 82 0.6× 75 0.6× 24 473
Rima Youil United States 13 322 0.8× 469 1.5× 130 0.5× 139 1.0× 115 0.9× 22 758
Jesse K. Mackey United States 15 380 1.0× 407 1.3× 201 0.8× 99 0.7× 145 1.1× 19 675
Chenghao Huang China 14 139 0.4× 240 0.7× 124 0.5× 384 2.8× 65 0.5× 28 727
Jennifer Sexton United States 12 102 0.3× 180 0.6× 162 0.6× 29 0.2× 82 0.6× 18 567
Huaxin Si United States 12 76 0.2× 113 0.4× 356 1.4× 348 2.5× 64 0.5× 17 595
Martin Lechmann Germany 15 98 0.3× 269 0.8× 92 0.4× 439 3.2× 99 0.8× 30 1.1k
Sylvie Roy Canada 9 99 0.3× 189 0.6× 101 0.4× 106 0.8× 59 0.5× 10 468
James Ch’ng United States 6 87 0.2× 205 0.6× 73 0.3× 124 0.9× 153 1.2× 7 503
Henry Ogbomo Canada 17 77 0.2× 182 0.6× 142 0.6× 194 1.4× 166 1.3× 28 774

Countries citing papers authored by Dennis Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Dennis Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Hoffmann more than expected).

Fields of papers citing papers by Dennis Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Hoffmann. The network helps show where Dennis Hoffmann may publish in the future.

Co-authorship network of co-authors of Dennis Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Hoffmann. A scholar is included among the top collaborators of Dennis Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Hoffmann. Dennis Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liss, Blasius, et al.. (2015). 1,3‐ß‐D‐glucan concentrations in blood products predict false positive post‐transfusion results. Mycoses. 59(1). 39–42. 21 indexed citations
2.
Liss, Blasius, et al.. (2015). 1,3-β-d-Glucan contamination of common antimicrobials: Table 1.. Journal of Antimicrobial Chemotherapy. 71(4). 913–915. 36 indexed citations
3.
Potthoff, Anja, Ghulam Nabi, Dennis Hoffmann, et al.. (2009). Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines. Vaccine. 27(21). 2768–2774. 11 indexed citations
4.
Esimone, Charles Okechukwu, et al.. (2009). Dammarenolic acid, a secodammarane triterpenoid from Aglaia sp. shows potent anti-retroviral activity in vitro. Phytomedicine. 17(7). 540–547. 33 indexed citations
5.
Hoffmann, Dennis, Thomas Grünwald, Wibke Bayer, & Oliver Wildner. (2008). Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia. World Journal of Gastroenterology. 14(12). 1842–1842. 3 indexed citations
6.
Hoffmann, Dennis, Bernhard Meyer, & Oliver Wildner. (2007). Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses. The Journal of Gene Medicine. 9(9). 764–778. 34 indexed citations
7.
Hoffmann, Dennis & Oliver Wildner. (2007). Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment. Cancer Gene Therapy. 14(7). 627–639. 26 indexed citations
8.
Bayer, Wibke, Simone Schimmer, Dennis Hoffmann, Ulf Dittmer, & Oliver Wildner. (2007). Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies. Vaccine. 26(5). 716–726. 18 indexed citations
9.
Hoffmann, Dennis, Wibke Bayer, & Oliver Wildner. (2007). Local and Distant Immune-Mediated Control of Colon Cancer Growth with Fusogenic Membrane Glycoproteins in Combination with Viral Oncolysis. Human Gene Therapy. 18(5). 435–450. 16 indexed citations
10.
Hoffmann, Dennis, Wibke Bayer, Albert Heim, et al.. (2007). Evaluation of Twenty-One Human Adenovirus Types and One Infectivity-Enhanced Adenovirus for the Treatment of Malignant Melanoma. Journal of Investigative Dermatology. 128(4). 988–998. 24 indexed citations
11.
Hoffmann, Dennis, Wibke Bayer, & Oliver Wildner. (2007). In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines. World Journal of Gastroenterology. 13(22). 3063–3063. 12 indexed citations
12.
13.
Hoffmann, Dennis & Oliver Wildner. (2006). Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy. Molecular Cancer Therapeutics. 5(8). 2013–2022. 20 indexed citations
14.
Hoffmann, Dennis, Albert Heim, Dirk M. Nettelbeck, Lars Steinstraesser, & Oliver Wildner. (2006). Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft tissue Sarcoma. Human Gene Therapy. 0(0). 601570817–601570817. 1 indexed citations
15.
Hoffmann, Dennis, Albert Heim, Dirk M. Nettelbeck, Lars Steinstraesser, & Oliver Wildner. (2006). Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft Tissue Sarcoma. Human Gene Therapy. 0(0). 1626286817–1626286817. 1 indexed citations
16.
Hoffmann, Dennis, et al.. (2006). Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer. Gene Therapy. 13(21). 1534–1544. 37 indexed citations
17.
Hoffmann, Dennis, Christian Jogler, & Oliver Wildner. (2005). Effects of the Ad5 upstream E1 region and gene products on heterologous promoters. The Journal of Gene Medicine. 7(10). 1356–1366. 15 indexed citations
18.
Wildner, Oliver, Dennis Hoffmann, Christian Jogler, & Klaus Überla. (2003). Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Cancer Gene Therapy. 10(10). 791–802. 32 indexed citations
19.
Stüber, Werner, et al.. (1995). Preparation and evaluation of PEG-bound thrombin inhibitors based on 4-amidinophenylalanine.. PubMed. 8(2). 78–85. 10 indexed citations
20.
Czech, Jörg, et al.. (1995). ANTITUMORAL ACTIVITY OF FLAVONE L-86-8275. International Journal of Oncology. 6(1). 31–6. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao‐Mei Rao Breakdown of academic impact, for papers by Rima Youil Breakdown of academic impact, for papers by Jesse K. Mackey Breakdown of academic impact, for papers by Chenghao Huang Breakdown of academic impact, for papers by Jennifer Sexton Breakdown of academic impact, for papers by Huaxin Si Breakdown of academic impact, for papers by Martin Lechmann Breakdown of academic impact, for papers by Sylvie Roy Breakdown of academic impact, for papers by James Ch’ng Breakdown of academic impact, for papers by Henry Ogbomo
Rankless by CCL
2026